Crucial test to identify those who have recovered from COVID-19 and have active immunity
Excerpt from the article:
“A test that can determine if a patient had been infected and recovered from COVID-19 is being developed at Mayo Clinic Laboratories. The test will detect the presence of antibodies specific to SARS-CoV-2, the virus that causes COVID-19. Antibodies are produced by a person’s immune system, and are critical for control and clearance of the virus.
Dr. Gregory Poland, a Mayo Clinic COVID-19 and vaccine expert, explains how the public and research will benefit from this antibody, or serologic, test.”
Click the button below to read the entire article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?